Actor portrayal. Not an actual patient.

BASAGLAR^® (insulin glargine) injection 100 units/mL is your beginsulin^®

In patients with type 1 diabetes, BASAGLAR must be used with mealtime insulin.

INDICATION

BASAGLAR is a long-acting insulin that is only available with a prescription. It is used to control high blood sugar in:

adults with type 1 or type 2 diabetes
children with type 1 diabetes

LIMITATION OF USE

BASAGLAR is not used to treat diabetic ketoacidosis.

It is not known if BASAGLAR is safe and effective in children with type 2 diabetes or in children younger than 6 years with type 1 diabetes. There were no studies done with BASAGLAR in these groups of children. If your doctor decides to give your child BASAGLAR, he or she may give you special instructions.

SELECT SAFETY INFORMATION

Warnings

Do not take BASAGLAR if you have:

symptoms of low blood sugar (hypoglycemia) or
an allergy to BASAGLAR or any of its ingredients.

Need help paying for your BASAGLAR prescription?

Lilly is committed to helping people with diabetes access affordable medicines.

Download your $35/month Insulin Savings Card

I have commercial insurance

I pay cash

Through the Lilly Insulin Value Program, all Lilly insulins are available for $35 a month whether you have commercial insurance or no insurance.^*

These savings cover all Lilly insulins.

^*Terms and conditions apply. At retail pharmacies. Government restrictions exclude people enrolled in federal government insurance programs from Lilly's $35 solutions. But federal law provides that Medicare Part D beneficiaries also pay no more than $35 per month for insulin.

Learn more about the Lilly Insulin Affordability Program

Terms, Conditions and Limitations apply to the Insulin Value Savings Card. Click on the following sections for details.

By using the Lilly Insulin Value Cash Savings Card Program (“Card”), you attest that you meet the eligibility criteria, and you agree to comply with the terms and conditions described below:

Card Eligibility:

You have been prescribed one of the following Lilly Insulin Value products (“Covered Insulin”) consistent with FDA approved product labeling: BASAGLAR^® KwikPen^® (insulin glargine) injection (100 units/mL), BASAGLAR ^® Tempo Pen^®, Humalog^® U-100 cartridge (insulin lispro) injection (100 units per mL), Humalog^® U-100 KwikPen^®, Humalog^® U-100 vial (10 mL), Humalog^® Junior KwikPen^®, Humalog^® U-200 KwikPen^®, Humalog^® Mix50/50^™ KwikPen^® (insulin lispro protamine and insulin lispro) injectable suspension (100 units per mL), Humalog^® Mix50/50^™ vial (10 mL), Humalog^® Mix75/25^™ KwikPen^®(insulin lispro protamine and insulin lispro) injectable suspension (100 units per mL), Humalog^® Mix75/25^™ vial (10 mL), Humalog^® Tempo Pen^®, Humulin^® N KwikPen^®(insulin isophane human) injectable suspension (100 units per mL) , Humulin^® N vial (10 mL), Humulin^® 70/30 KwikPen^® (insulin isophane human and insulin human) injectable suspension (100 units per mL) , Humulin^® 70/30 vial (10 mL), Humulin^® R (insulin human) injection (10 mL), Humulin^® R U-500 KwikPen^® (insulin human) injection (500 units/mL), Humulin R U-500 vial, Insulin Lispro KwikPen^® injection (100 units per mL), Insulin Lispro injection vial (10mL), Insulin Lispro Junior KwikPen^® injection, Insulin Lispro Protamine and Insulin Lispro Mix75/25^™ KwikPen^® Injectable Suspension, Lyumjev^® KwikPen^® (insulin lispro-aabc) injection (100 units/mL), Lyumjev^® U-200 KwikPen^®, Lyumjev^® U-100 vial (10 mL), Lyumjev^® Tempo Pen^®, and REZVOGLAR™ KwikPen (insulin glargine-aglr) injection (100 units/mL).
You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE^®/CHAMPUS, or any state prescription drug assistance program.
You are a resident of the United States or a United States Territory (Puerto Rico, Guam, U.S. Virgin Islands, Northern Mariana Islands, American Samoa)
You are 18 years of age or older

Card Terms and Conditions
You must have a prescription consistent with FDA-approved product labeling to pay as little as $35 for a 1-month prescription fill of your Covered Insulin. Month is defined as 30-days. Card savings are subject to a maximum monthly savings of wholesale acquisition cost plus usual and customary pharmacy charges per prescription fill, up to a maximum of 14 prescription fills per calendar year for each Covered Insulin. Subject to Lilly USA, LLC’s (“Lilly”) right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason, Card expires and savings end on 12/31/2024.

Additional Program Terms and Conditions
If you have an insurance plan that is participating in an alternate funding program (“AFP”) (examples include, but are not limited to, ImpaxRX, Payer Matrix, SHARx, Script Sourcing, and Paydhealth) that requires you to apply to the Lilly Insulin Value Cash Savings Card Program or otherwise pursue specialty drug prescription coverage through an alternate funding vendor as a condition of, requirement for, or prerequisite to coverage of your Covered Insulin, you are not eligible for and are prohibited from using the Lilly Insulin Value Cash Savings Card Program. AFPs include programs where coverage, reimbursement, or patient out of pocket costs for a product in some way vary based on the availability of a manufacturer co-pay program. AFPs may modify, delay, deny, restrict, or withhold insurance benefits or coverage from patients, or exclude Lilly products from coverage contingent upon a member's use of Lilly Insulin Value Cash Savings Card Program. You agree to inform Lilly Insulin Value Cash Savings Card Program if you are or become a member of such an alternative funding program. You are responsible for any applicable taxes, fees, and any amount that exceeds the monthly or annual maximum Card savings. Monthly and annual maximum savings are set at Lilly's sole and absolute discretion and may be changed with or without notice at any time for any reason. At its sole discretion and with or without notice, Lilly may reduce, eliminate, or otherwise modify the Card savings for any reason including but not limited to if your commercial drug insurance plan imposes additional requirements which limits or prevents you from receiving coverage for your Covered Insulin, only allows partial coverage for your Covered Insulin, removes coverage for your Covered Insulin and requires you to utilize the Card, does not provide a material level of financial assistance for the cost of your Covered Insulin, or does not apply Card payments to satisfy your co-payment, deductible, or coinsurance for your Covered Insulin. Card savings are not valid for: Massachusetts residents if an AB-rated generic equivalent is available; California residents if an FDA-approved therapeutic equivalent is available. You must meet the Card eligibility criteria, terms and conditions every time you use the Card. Card activation is required. No party may seek reimbursement from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Card. Card savings cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving your Covered Insulin. You agree that this Card savings is intended solely for the benefit of you, the patient, and that the Card benefits are nontransferable. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade, or to counterfeit the Card. The Card is not insurance. Lilly has the sole right to interpret and apply Card eligibility criteria, and terms and conditions. Card eligibility, and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Eligibility criteria, and terms and conditions for the Lilly Insulin Value Cash Savings Card Program may change from time to time; the most current version can be found at https://www.insulinaffordability.com. You may be required to obtain a new Card, including if any Card terms and conditions have been terminated, rescinded, revoked, or amended by Lilly. Card void where prohibited by law. Subject to Lilly’s right to terminate, rescind, revoke or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason, the Card expires and savings end on 12/31/2024.

By using the Lilly Insulin Value Savings Card Program (“Card”), you attest that you meet the eligibility criteria, and you agree to comply with the terms and conditions described below:

Card Eligibility:

You have been prescribed one of the following Lilly Insulin Value products (“Covered Insulin”) consistent with FDA approved product labeling: BASAGLAR^® KwikPen^® (insulin glargine) injection (100 units/mL), BASAGLAR ^® Tempo Pen^®, Humalog^® U-100 cartridge (insulin lispro) injection (100 units per mL), Humalog^® U-100 KwikPen^®, Humalog^® U-100 vial (10 mL), Humalog^® Junior KwikPen^®, Humalog^® U-200 KwikPen^®, Humalog^® Mix50/50^™ KwikPen^® (insulin lispro protamine and insulin lispro) injectable suspension (100 units per mL), Humalog^® Mix50/50^™ vial (10 mL), Humalog^® Mix75/25^™ KwikPen^®(insulin lispro protamine and insulin lispro) injectable suspension (100 units per mL), Humalog^® Mix75/25^™ vial (10 mL), Humalog^® Tempo Pen^®, Humulin^® N KwikPen^®(insulin isophane human) injectable suspension (100 units per mL) , Humulin^® N vial (10 mL), Humulin^® 70/30 KwikPen^® (insulin isophane human and insulin human) injectable suspension (100 units per mL) , Humulin^® 70/30 vial (10 mL), Humulin^® R (insulin human) injection (10 mL), Humulin^® R U-500 KwikPen^® (insulin human) injection (500 units/mL), Humulin R U-500 vial, Insulin Lispro KwikPen^® injection (100 units per mL), Insulin Lispro injection vial (10mL), Insulin Lispro Junior KwikPen^® injection, Insulin Lispro Protamine and Insulin Lispro Mix75/25^™ KwikPen^® Injectable Suspension, Lyumjev^® KwikPen^® (insulin lispro-aabc) injection (100 units/mL), Lyumjev^® U-200 KwikPen^®, Lyumjev^® U-100 vial (10 mL), Lyumjev^® Tempo Pen^®, and REZVOGLAR^™ KwikPen (insulin glargine-aglr) injection (100 units/mL).
You are enrolled in a commercial drug insurance plan
You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE^®/CHAMPUS, or any state prescription drug assistance program.
You are a resident of the United States or a United States Territory (Puerto Rico, Guam, U.S. Virgin Islands, Northern Mariana Islands, American Samoa)
You are 18 years of age or older

Card Terms and Conditions

For patients with commercial drug insurance coverage for your Covered Insulin: You must have commercial drug insurance that covers your Covered Insulin and a prescription consistent with FDA-approved product labeling to pay as little as $35 for a 1-month prescription fill of your Covered Insulin. Month is defined as 30-days. Card savings are subject to a maximum monthly savings of up to $3,000 per prescription fill of each Covered Insulin and separate maximum annual savings of up to $16,000 per calendar year for each Covered Insulin. Card may be used for a maximum of up to 16 prescription fills per calendar year for each Covered Insulin. Subject to Lilly USA, LLC’s (“Lilly”) right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason, Card expires and savings end on 12/31/2024.

For patients with commercial drug insurance who do not have coverage for your Covered Insulin: You must have commercial drug insurance that does not cover your Covered Insulin and a prescription consistent with FDA-approved product labeling to pay as little as $35 for a 1-month prescription fill of your Covered Insulin. Month is defined as 30-days. Card savings are subject to a maximum monthly savings of wholesale acquisition cost plus usual and customary pharmacy charges per prescription fill, up to a maximum of 14 prescription fills per calendar year for each Covered Insulin. Subject to Lilly’s right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason, Card expires and savings end on 12/31/2024.

Additional Program Terms and Conditions
If you have an insurance plan that is participating in an alternate funding program (“AFP”) (examples include, but are not limited to, ImpaxRX, Payer Matrix, SHARx, Script Sourcing, and Paydhealth) that requires you to apply to the Lilly Insulin Value Savings Card Program or otherwise pursue specialty drug prescription coverage through an alternate funding vendor as a condition of, requirement for, or prerequisite to coverage of your Covered Insulin, you are not eligible for and are prohibited from using the Lilly Insulin Value Savings Card Program. AFPs include programs where coverage, reimbursement, or patient out of pocket costs for a product in some way vary based on the availability of a manufacturer co-pay program. AFPs may modify, delay, deny, restrict, or withhold insurance benefits or coverage from patients, or exclude Lilly products from coverage contingent upon a member’s use of Lilly Insulin Value Savings Card Program. You agree to inform Lilly Insulin Value Savings Card Program if you are or become a member of such an alternative funding program. You are responsible for any applicable taxes, fees, and any amount that exceeds the monthly or annual maximum Card savings. Monthly and annual maximum savings are set at Lilly’s sole and absolute discretion and may be changed with or without notice at any time for any reason. At its sole discretion and with or without notice, Lilly may reduce, eliminate, or otherwise modify the Card savings for any reason, including but not limited to if your commercial drug insurance plan imposes additional requirements which limits or prevents you from receiving coverage for your Covered Insulin, only allows partial coverage for your Covered Insulin, removes coverage for your Covered Insulin and requires you to utilize the Card, does not provide a material level of financial assistance for the cost of your Covered Insulin, or does not apply Card payments to satisfy your co-payment, deductible, or coinsurance for your Covered Insulin. Card savings are not valid for: Massachusetts residents if an AB-rated generic equivalent is available; California residents if an FDA-approved therapeutic equivalent is available. You must meet the Card eligibility criteria, terms and conditions every time you use the Card. Card activation is required. No party may seek reimbursement from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Card. By utilizing the Card, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you will notify your Insurance Carrier of your redemption of the Card. Card savings cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving your Covered Insulin. You agree that this Card savings is intended solely for the benefit of you, the patient, and that the Card benefits are nontransferable. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade, or to counterfeit the Card. The Card is not insurance. Lilly has the sole right to interpret and apply Card eligibility criteria, and terms and conditions. Card eligibility, and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Eligibility criteria, and terms and conditions for the Lilly Insulin Value Savings Card Program may change from time to time; the most current version can be found at https://www.insulinaffordability.com. You may be required to obtain a new Card, including if any Card terms and conditions have been terminated, rescinded, revoked, or amended by Lilly. Card void where prohibited by law. Subject to Lilly’s right to terminate, rescind, revoke or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason, the Card expires and savings end on 12/31/2024.

Anyone who uses Lilly insulin and needs help with diabetes care can call the Lilly Diabetes Solution Center. A live representative will have a confidential conversation and present solutions that are based on each person's circumstances. The helpline is available Monday through Friday.

Call 1-833-808-1234

Solutions vary by product and are subject to change and eligibility.

When it’s time to start taking insulin, you may wonder what it’s like to begin or how to fit it into your life

Your doctor recommended BASAGLAR because it’s a long-acting insulin, which means it’s a good place to begin for people new to insulin.

Learn more about BASAGLAR

Answers to your questions about insulin

It’s normal to have a lot of questions when starting insulin. Whether you and your doctor are still discussing insulin or you’ve already been prescribed BASAGLAR, you’ve come to the right place. See what insulin is and how it may help people with diabetes.

Wondering about your routine with insulin?

We’ll explain how to use BASAGLAR, ways you can establish a good routine, where to inject, and more.

SELECT SAFETY INFORMATION
Warnings
Do not reuse needles or share your Basaglar prefilled pen with other people. You or the other person can get a serious infection. This can happen even if you change the needle.

Looking for resources designed to help you start insulin?

BASAGLAR goes beyond just insulin by offering support you may need. Check out our resources designed to help you start basal insulin therapy, support that may help you save on BASAGLAR, and contacts for additional support.

SELECT SAFETY INFORMATION
Warnings
Do not change the insulin you use or your dose, unless your doctor tells you to. This could cause low or high blood sugar, which could be serious. Do not inject your insulin into the exact same spot or where the skin has pit or lumps. Avoid injecting into thickened, tender, bruised, scaly, hard, or damaged skin.

LillyDirect: Connect to Care

Get speed, convenience, and access to focused care with independent telehealth or in-person providers through LillyDirect.

Get started

SAFETY SUMMARY

Warnings -

Do not take BASAGLAR if you have:

symptoms of low blood sugar (hypoglycemia)
an allergy to BASAGLAR or any of its ingredients

Do not reuse needles or share your BASAGLAR prefilled pen with other people. You or the other person can get a serious infection. This can happen even if you change the needle.

Do not change the insulin you use or your dose, unless your doctor tells you to. This could cause low or high blood sugar, which could be serious.

BASAGLAR may cause serious side effects. Some of these can lead to death. The possible serious side effects of BASAGLAR are:

Low blood sugar. This can lead to:
- dizziness or light-headedness
- headache
- shakiness
- irritability
- sweating
- blurred vision
- fast heartbeat
- mood change
- confusion
- slurred speech
- anxiety
- hunger
Severe allergic reaction.
Get emergency help right away if you have:
- a rash over your whole body
- swelling of your face, tongue, or throat
- extreme drowsiness, dizziness, or confusion
- trouble breathing
- sweating
- a fast heartbeat
- shortness of breath
Low potassium in your blood. This can lead to severe breathing problems, irregular heartbeat, and death.
Heart failure. Taking diabetes pills called thiazolidinediones /thIE-uh-zOH-li-dEEn-dIE-OHns/ (TZDs) with BASAGLAR may cause heart failure in some people. This includes people who do not have any heart problems. If you have heart failure, it may get worse if you take TZDs with BASAGLAR. Tell your doctor if you have any new symptoms of heart failure, or if they get worse. These are: shortness of breath, swelling of the ankles or feet, and sudden weight gain. Your doctor may need to change or stop treatment with TZDs and BASAGLAR.

Common side effects

The most common side effects of BASAGLAR are:

low blood sugar
minor reactions where you have injected BASAGLAR
itching
swelling

allergic reactions
changes in fat tissue where you have injected BASAGLAR
rash
weight gain

These are not all of the possible side effects. Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using

Talk with your doctor about low blood sugar and how to manage it. Tell your doctor:

about all of the medicines you take, including over-the-counter medicines, vitamins, and herbal supplements.
about any other prescription medicines you take, especially ones called TZDs.
about all of your medical conditions, including if you have heart failure or other heart, liver, or kidney problems. If you have heart failure, it may get worse while you take TZDs with BASAGLAR.
if you are pregnant, breastfeeding, or plan to become pregnant. It is not known if BASAGLAR may harm your unborn or breastfeeding baby.

How to take

The BASAGLAR prefilled pen is a disposable insulin delivery device for use by a single patient to inject BASAGLAR. Read the Instructions for Use that come with your BASAGLAR prefilled pen. These instructions provide details on how to prepare and inject a dose of BASAGLAR, and how to throw away used BASAGLAR prefilled pens and needles.

Be sure to check your blood sugar levels and use BASAGLAR exactly as your doctor tells you to. Your doctor may tell you to change your dose because of illness, increased stress, or changes in your weight, diet, or level of physical activity or exercise. He or she may also tell you to change your dose because of other medicines you take.

Before injecting your BASAGLAR
You can inject BASAGLAR yourself, or you can have a trained caregiver inject it for you. Make sure you or your caregiver:

Check your insulin label each time you give your injection. This will help you make sure that you are using the correct insulin.
Use a new needle for each injection. You can get a serious infection or the wrong dose of insulin if you re-use needles.

When you are ready to inject

Take BASAGLAR once a day, at the same time each day.
Change (rotate) where you inject your insulin with each dose. This can help reduce your chance of getting pits, lumps, or thickened skin where you inject your insulin. Do not inject your insulin into the exact same spot or where the skin has pits or lumps. Avoid injecting into thickened, tender, bruised, scaly, hard, scarred, or damaged skin.

Staying safe while taking your BASAGLAR

To stay safe while taking BASAGLAR, be sure you only use BASAGLAR that is clear and colorless and does not have any particles.

Be sure you do not:

mix BASAGLAR with any other type of insulin or solution.
drive or use heavy machinery until you know how BASAGLAR affects you.
drink alcohol or use other medicines that contain alcohol when taking BASAGLAR.

Learn more

BASAGLAR is a prescription medicine. For more information, call 1-800-545-5979.

This summary provides basic information about BASAGLAR but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other health care provider about BASAGLAR and how to take it. Your doctor is the best person to help you decide if BASAGLAR is right for you.

BV CON BS 14SEP2022

BASAGLAR^® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

INDICATION

BASAGLAR^® (bāz-a-glar) is a long-acting insulin used to control high blood sugar in:

adults with type 1 or type 2 diabetes
children with type 1 diabetes